OPTUM RX COST ADVANTAGE Trademark

Trademark Overview


On Thursday, January 11, 2024, a trademark application was filed for OPTUM RX COST ADVANTAGE with the United States Patent and Trademark Office. The USPTO has given the OPTUM RX COST ADVANTAGE trademark a serial number of 98353351. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Wednesday, July 30, 2025. This trademark is owned by Optum, Inc.. The OPTUM RX COST ADVANTAGE trademark is filed in the Insurance & Financial Services category with the following description:

Insurance administration of prescription drug benefit plans; Pharmacy benefit management services
optum rx cost advantage

General Information


Serial Number98353351
Word MarkOPTUM RX COST ADVANTAGE
Filing DateThursday, January 11, 2024
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateWednesday, July 30, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 13, 2024

Trademark Statements


Goods and ServicesInsurance administration of prescription drug benefit plans; Pharmacy benefit management services
NOT AVAILABLE"RX COST"

Classification Information


International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, January 11, 2024
Primary Code036
First Use Anywhere DateTuesday, November 1, 2022
First Use In Commerce DateTuesday, November 1, 2022

Trademark Owner History


Party NameOptum, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEden Prairie, MN 55344

Party NameOptum, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMinnetonka, MN 55343

Trademark Events


Event DateEvent Description
Thursday, January 11, 2024NEW APPLICATION ENTERED
Friday, May 3, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 2, 2024ASSIGNED TO EXAMINER
Wednesday, July 3, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, July 3, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, July 3, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, July 3, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, July 3, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 24, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 13, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 8, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 31, 2025USE AMENDMENT FILED
Monday, March 31, 2025TEAS STATEMENT OF USE RECEIVED
Tuesday, August 13, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 24, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, July 6, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 30, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, July 30, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, July 9, 2025STATEMENT OF USE PROCESSING COMPLETE
Tuesday, June 24, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 24, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 24, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 24, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 24, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS